世界の医薬品用マリファナ（MMJ）市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Pharmaceutical Marijuana (MMJ) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14895 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、医薬品用マリファナ（MMJ）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。医薬品用マリファナ（MMJ）の種類別市場規模（THC優勢、CBD優勢、バランスTHC・CBD）、用途別市場規模（癌、関節炎、片頭痛、癲癇、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・医薬品用マリファナ（MMJ）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Canopy Growth Corporation、GW Pharmaceuticals, plc、Aurora Cannabis, Inc.、Aphria, Inc.、MedReleaf Corporation、Insys Therapeutics, Inc.、CanniMed Therapeutics, Inc.、Cara Therapeutics, Inc.、United Cannabis Corporation ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：THC優勢、CBD優勢、バランスTHC・CBD ・用途別分析2016年-2026年：癌、関節炎、片頭痛、癲癇、その他 ・医薬品用マリファナ（MMJ）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・医薬品用マリファナ（MMJ）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・医薬品用マリファナ（MMJ）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・医薬品用マリファナ（MMJ）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・医薬品用マリファナ（MMJ）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Pharmaceutical Marijuana (MMJ) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pharmaceutical Marijuana (MMJ) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Pharmaceutical Marijuana (MMJ) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Pharmaceutical Marijuana (MMJ) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
THC-dominant
CBD-dominant
Balanced THC & CBD

Market segment by Application can be divided into
Cancer
Arthritis
Migraine
Epilepsy
Others

The key market players for global Pharmaceutical Marijuana (MMJ) market are listed below:
Canopy Growth Corporation
GW Pharmaceuticals, plc
Aurora Cannabis, Inc.
Aphria, Inc.
MedReleaf Corporation
Insys Therapeutics, Inc.
CanniMed Therapeutics, Inc.
Cara Therapeutics, Inc.
United Cannabis Corporation

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pharmaceutical Marijuana (MMJ) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pharmaceutical Marijuana (MMJ), with price, sales, revenue and global market share of Pharmaceutical Marijuana (MMJ) from 2019 to 2021.
Chapter 3, the Pharmaceutical Marijuana (MMJ) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceutical Marijuana (MMJ) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pharmaceutical Marijuana (MMJ) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pharmaceutical Marijuana (MMJ) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Pharmaceutical Marijuana (MMJ) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pharmaceutical Marijuana (MMJ) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 THC-dominant
1.2.3 CBD-dominant
1.2.4 Balanced THC & CBD
1.3 Market Analysis by Application
1.3.1 Overview: Global Pharmaceutical Marijuana (MMJ) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Arthritis
1.3.4 Migraine
1.3.5 Epilepsy
1.3.6 Others
1.4 Global Pharmaceutical Marijuana (MMJ) Market Size & Forecast
1.4.1 Global Pharmaceutical Marijuana (MMJ) Sales in Value (2016-2026))
1.4.2 Global Pharmaceutical Marijuana (MMJ) Sales in Volume (2016-2026)
1.4.3 Global Pharmaceutical Marijuana (MMJ) Price by Type (2016-2026) & (US$/Unit)
1.5 Global Pharmaceutical Marijuana (MMJ) Production Capacity Analysis
1.5.1 Global Pharmaceutical Marijuana (MMJ) Total Production Capacity (2016-2026)
1.5.2 Global Pharmaceutical Marijuana (MMJ) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceutical Marijuana (MMJ) Market Drivers
1.6.2 Pharmaceutical Marijuana (MMJ) Market Restraints
1.6.3 Pharmaceutical Marijuana (MMJ) Trends Analysis
2 Manufacturers Profiles
2.1 Canopy Growth Corporation
2.1.1 Canopy Growth Corporation Details
2.1.2 Canopy Growth Corporation Major Business
2.1.3 Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Product and Services
2.1.4 Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 GW Pharmaceuticals, plc
2.2.1 GW Pharmaceuticals, plc Details
2.2.2 GW Pharmaceuticals, plc Major Business
2.2.3 GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Product and Services
2.2.4 GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Aurora Cannabis, Inc.
2.3.1 Aurora Cannabis, Inc. Details
2.3.2 Aurora Cannabis, Inc. Major Business
2.3.3 Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
2.3.4 Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Aphria, Inc.
2.4.1 Aphria, Inc. Details
2.4.2 Aphria, Inc. Major Business
2.4.3 Aphria, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
2.4.4 Aphria, Inc. Pharmaceutical Marijuana (MMJ) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 MedReleaf Corporation
2.5.1 MedReleaf Corporation Details
2.5.2 MedReleaf Corporation Major Business
2.5.3 MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Product and Services
2.5.4 MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Insys Therapeutics, Inc.
2.6.1 Insys Therapeutics, Inc. Details
2.6.2 Insys Therapeutics, Inc. Major Business
2.6.3 Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
2.6.4 Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 CanniMed Therapeutics, Inc.
2.7.1 CanniMed Therapeutics, Inc. Details
2.7.2 CanniMed Therapeutics, Inc. Major Business
2.7.3 CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
2.7.4 CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Cara Therapeutics, Inc.
2.8.1 Cara Therapeutics, Inc. Details
2.8.2 Cara Therapeutics, Inc. Major Business
2.8.3 Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
2.8.4 Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 United Cannabis Corporation
2.9.1 United Cannabis Corporation Details
2.9.2 United Cannabis Corporation Major Business
2.9.3 United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Product and Services
2.9.4 United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Pharmaceutical Marijuana (MMJ) Sales by Manufacturer
3.1 Global Pharmaceutical Marijuana (MMJ) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pharmaceutical Marijuana (MMJ) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pharmaceutical Marijuana (MMJ)
3.4 Market Concentration Rate
3.4.1 Top 3 Pharmaceutical Marijuana (MMJ) Manufacturer Market Share
3.4.2 Top 6 Pharmaceutical Marijuana (MMJ) Manufacturer Market Share
3.5 Global Pharmaceutical Marijuana (MMJ) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pharmaceutical Marijuana (MMJ) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pharmaceutical Marijuana (MMJ) Market Size by Region
4.1.1 Global Pharmaceutical Marijuana (MMJ) Sales in Volume by Region (2016-2026)
4.1.2 Global Pharmaceutical Marijuana (MMJ) Revenue by Region (2016-2026)
4.2 North America Pharmaceutical Marijuana (MMJ) Revenue (2016-2026)
4.3 Europe Pharmaceutical Marijuana (MMJ) Revenue (2016-2026)
4.4 Asia-Pacific Pharmaceutical Marijuana (MMJ) Revenue (2016-2026)
4.5 South America Pharmaceutical Marijuana (MMJ) Revenue (2016-2026)
4.6 Middle East and Africa Pharmaceutical Marijuana (MMJ) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pharmaceutical Marijuana (MMJ) Sales in Volume by Type (2016-2026)
5.2 Global Pharmaceutical Marijuana (MMJ) Revenue by Type (2016-2026)
5.3 Global Pharmaceutical Marijuana (MMJ) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pharmaceutical Marijuana (MMJ) Sales in Volume by Application (2016-2026)
6.2 Global Pharmaceutical Marijuana (MMJ) Revenue by Application (2016-2026)
6.3 Global Pharmaceutical Marijuana (MMJ) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2026)
7.2 North America Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2026)
7.3 North America Pharmaceutical Marijuana (MMJ) Market Size by Country
7.3.1 North America Pharmaceutical Marijuana (MMJ) Sales in Volume by Country (2016-2026)
7.3.2 North America Pharmaceutical Marijuana (MMJ) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2026)
8.2 Europe Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2026)
8.3 Europe Pharmaceutical Marijuana (MMJ) Market Size by Country
8.3.1 Europe Pharmaceutical Marijuana (MMJ) Sales in Volume by Country (2016-2026)
8.3.2 Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2026)
9.2 Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2026)
9.3 Asia-Pacific Pharmaceutical Marijuana (MMJ) Market Size by Region
9.3.1 Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2026)
10.2 South America Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2026)
10.3 South America Pharmaceutical Marijuana (MMJ) Market Size by Country
10.3.1 South America Pharmaceutical Marijuana (MMJ) Sales in Volume by Country (2016-2026)
10.3.2 South America Pharmaceutical Marijuana (MMJ) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2026)
11.2 Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2026)
11.3 Middle East & Africa Pharmaceutical Marijuana (MMJ) Market Size by Country
11.3.1 Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pharmaceutical Marijuana (MMJ) Typical Distributors
12.3 Pharmaceutical Marijuana (MMJ) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Pharmaceutical Marijuana (MMJ) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pharmaceutical Marijuana (MMJ) Revenue by Application, (USD Million), 2021-2026
Table 3. Canopy Growth Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Canopy Growth Corporation Major Business
Table 5. Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Product and Services
Table 6. Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GW Pharmaceuticals, plc Basic Information, Manufacturing Base and Competitors
Table 8. GW Pharmaceuticals, plc Major Business
Table 9. GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Product and Services
Table 10. GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Aurora Cannabis, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Aurora Cannabis, Inc. Major Business
Table 13. Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
Table 14. Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Aphria, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Aphria, Inc. Major Business
Table 17. Aphria, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
Table 18. Aphria, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. MedReleaf Corporation Basic Information, Manufacturing Base and Competitors
Table 20. MedReleaf Corporation Major Business
Table 21. MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Product and Services
Table 22. MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Insys Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Insys Therapeutics, Inc. Major Business
Table 25. Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
Table 26. Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. CanniMed Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 28. CanniMed Therapeutics, Inc. Major Business
Table 29. CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
Table 30. CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Cara Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Cara Therapeutics, Inc. Major Business
Table 33. Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product and Services
Table 34. Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. United Cannabis Corporation Basic Information, Manufacturing Base and Competitors
Table 36. United Cannabis Corporation Major Business
Table 37. United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Product and Services
Table 38. United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Pharmaceutical Marijuana (MMJ) Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Pharmaceutical Marijuana (MMJ) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Pharmaceutical Marijuana (MMJ), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Pharmaceutical Marijuana (MMJ) Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Pharmaceutical Marijuana (MMJ) Production Site of Key Manufacturer
Table 44. Pharmaceutical Marijuana (MMJ) New Entrant and Capacity Expansion Plans
Table 45. Pharmaceutical Marijuana (MMJ) Mergers & Acquisitions in the Past Five Years
Table 46. Global Pharmaceutical Marijuana (MMJ) Sales by Region (2016-2021e) & (K Units)
Table 47. Global Pharmaceutical Marijuana (MMJ) Sales by Region (2021-2026) & (K Units)
Table 48. Global Pharmaceutical Marijuana (MMJ) Revenue by Region (2016-2021e) & (USD Million)
Table 49. Global Pharmaceutical Marijuana (MMJ) Revenue by Region (2021-2026) & (USD Million)
Table 50. Global Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2021e) & (K Units)
Table 51. Global Pharmaceutical Marijuana (MMJ) Sales by Type (2021-2026) & (K Units)
Table 52. Global Pharmaceutical Marijuana (MMJ) Revenue by Type (2016-2021e) & (USD Million)
Table 53. Global Pharmaceutical Marijuana (MMJ) Revenue by Type (2021-2026) & (USD Million)
Table 54. Global Pharmaceutical Marijuana (MMJ) Price by Type (2016-2021e) & (US$/Unit)
Table 55. Global Pharmaceutical Marijuana (MMJ) Price by Type (2021-2026) & (US$/Unit)
Table 56. Global Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2021e) & (K Units)
Table 57. Global Pharmaceutical Marijuana (MMJ) Sales by Application (2021-2026) & (K Units)
Table 58. Global Pharmaceutical Marijuana (MMJ) Revenue by Application (2016-2021e) & (USD Million)
Table 59. Global Pharmaceutical Marijuana (MMJ) Revenue by Application (2021-2026) & (USD Million)
Table 60. Global Pharmaceutical Marijuana (MMJ) Price by Application (2016-2021e) & (US$/Unit)
Table 61. Global Pharmaceutical Marijuana (MMJ) Price by Application (2021-2026) & (US$/Unit)
Table 62. North America Pharmaceutical Marijuana (MMJ) Sales by Country (2016-2021e) & (K Units)
Table 63. North America Pharmaceutical Marijuana (MMJ) Sales by Country (2021-2026) & (K Units)
Table 64. North America Pharmaceutical Marijuana (MMJ) Revenue by Country (2016-2021e) & (USD Million)
Table 65. North America Pharmaceutical Marijuana (MMJ) Revenue by Country (2021-2026) & (USD Million)
Table 66. North America Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2021e) & (K Units)
Table 67. North America Pharmaceutical Marijuana (MMJ) Sales by Type (2021-2026) & (K Units)
Table 68. North America Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2021e) & (K Units)
Table 69. North America Pharmaceutical Marijuana (MMJ) Sales by Application (2021-2026) & (K Units)
Table 70. Europe Pharmaceutical Marijuana (MMJ) Sales by Country (2016-2021e) & (K Units)
Table 71. Europe Pharmaceutical Marijuana (MMJ) Sales by Country (2021-2026) & (K Units)
Table 72. Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2016-2021e) & (USD Million)
Table 73. Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2021-2026) & (USD Million)
Table 74. Europe Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2021e) & (K Units)
Table 75. Europe Pharmaceutical Marijuana (MMJ) Sales by Type (2021-2026) & (K Units)
Table 76. Europe Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2021e) & (K Units)
Table 77. Europe Pharmaceutical Marijuana (MMJ) Sales by Application (2021-2026) & (K Units)
Table 78. Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales by Region (2016-2021e) & (K Units)
Table 79. Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales by Region (2021-2026) & (K Units)
Table 80. Asia-Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region (2016-2021e) & (USD Million)
Table 81. Asia-Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region (2021-2026) & (USD Million)
Table 82. Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2021e) & (K Units)
Table 83. Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales by Type (2021-2026) & (K Units)
Table 84. Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2021e) & (K Units)
Table 85. Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales by Application (2021-2026) & (K Units)
Table 86. South America Pharmaceutical Marijuana (MMJ) Sales by Country (2016-2021e) & (K Units)
Table 87. South America Pharmaceutical Marijuana (MMJ) Sales by Country (2021-2026) & (K Units)
Table 88. South America Pharmaceutical Marijuana (MMJ) Revenue by Country (2016-2021e) & (USD Million)
Table 89. South America Pharmaceutical Marijuana (MMJ) Revenue by Country (2021-2026) & (USD Million)
Table 90. South America Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2021e) & (K Units)
Table 91. South America Pharmaceutical Marijuana (MMJ) Sales by Type (2021-2026) & (K Units)
Table 92. South America Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2021e) & (K Units)
Table 93. South America Pharmaceutical Marijuana (MMJ) Sales by Application (2021-2026) & (K Units)
Table 94. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Country (2016-2021e) & (K Units)
Table 95. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Country (2021-2026) & (K Units)
Table 96. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2016-2021e) & (USD Million)
Table 97. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2021-2026) & (USD Million)
Table 98. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Type (2016-2021e) & (K Units)
Table 99. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Type (2021-2026) & (K Units)
Table 100. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Application (2016-2021e) & (K Units)
Table 101. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales by Application (2021-2026) & (K Units)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Pharmaceutical Marijuana (MMJ) Typical Distributors
Table 105. Pharmaceutical Marijuana (MMJ) Typical Customers
List of Figures
Figure 1. Pharmaceutical Marijuana (MMJ) Picture
Figure 2. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type in 2020
Figure 3. THC-dominant
Figure 4. CBD-dominant
Figure 5. Balanced THC & CBD
Figure 6. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application in 2020
Figure 7. Cancer
Figure 8. Arthritis
Figure 9. Migraine
Figure 10. Epilepsy
Figure 11. Others
Figure 12. Global Pharmaceutical Marijuana (MMJ) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Pharmaceutical Marijuana (MMJ) Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Pharmaceutical Marijuana (MMJ) Sales (2016-2026) & (K Units)
Figure 15. Global Pharmaceutical Marijuana (MMJ) Price by Type (2016-2026) & (US$/Unit)
Figure 16. Global Pharmaceutical Marijuana (MMJ) Production Capacity (2016-2026) & (K Units)
Figure 17. Global Pharmaceutical Marijuana (MMJ) Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Pharmaceutical Marijuana (MMJ) Market Drivers
Figure 19. Pharmaceutical Marijuana (MMJ) Market Restraints
Figure 20. Pharmaceutical Marijuana (MMJ) Market Trends
Figure 21. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Manufacturer in 2020
Figure 22. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Manufacturer in 2020
Figure 23. Pharmaceutical Marijuana (MMJ) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Pharmaceutical Marijuana (MMJ) Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Pharmaceutical Marijuana (MMJ) Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2016-2026)
Figure 27. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Region (2016-2026)
Figure 28. North America Pharmaceutical Marijuana (MMJ) Revenue (2016-2026) & (USD Million)
Figure 29. Europe Pharmaceutical Marijuana (MMJ) Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Pharmaceutical Marijuana (MMJ) Revenue (2016-2026) & (USD Million)
Figure 31. South America Pharmaceutical Marijuana (MMJ) Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue (2016-2026) & (USD Million)
Figure 33. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2016-2026)
Figure 34. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Type (2016-2026)
Figure 35. Global Pharmaceutical Marijuana (MMJ) Price by Type (2016-2026) & (US$/Unit)
Figure 36. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2016-2026)
Figure 37. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Application (2016-2026)
Figure 38. Global Pharmaceutical Marijuana (MMJ) Price by Application (2016-2026) & (US$/Unit)
Figure 39. North America Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2016-2026)
Figure 40. North America Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2016-2026)
Figure 41. North America Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2016-2026)
Figure 42. North America Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2016-2026)
Figure 43. United States Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2016-2026)
Figure 47. Europe Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2016-2026)
Figure 48. Europe Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2016-2026)
Figure 49. Europe Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2016-2026)
Figure 50. Germany Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Pharmaceutical Marijuana (MMJ) Revenue Market Share by Region (2016-2026)
Figure 59. China Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2016-2026)
Figure 66. South America Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2016-2026)
Figure 67. South America Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2016-2026)
Figure 68. South America Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Pharmaceutical Marijuana (MMJ) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source

---